SEC Form 4 · accession 0001562180-16-001355
Intersect ENT, Inc. · XENT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Stambaugh
Officer — VP Clinical Affairs
Period of report
Jan 15, 2016
Accepted (ET)
Jan 20, 2016 · 5:41 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001271214
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to buy)F1 | $18.90 | Jan 15, 2016 | A | 35,000 | A | — | Jan 14, 2026 | Common Stock | 35,000 | 35,000 | D |
Explanation of responses
- F1The shares subject to the option vest commencing January 1, 2016 in equal monthly installments over four years.